The negative effect of unloading exceeds the bone-sparing effect of alkaline supplementation: a bed rest study

Osteoporos Int. 2019 Feb;30(2):431-439. doi: 10.1007/s00198-018-4703-6. Epub 2018 Sep 25.

Abstract

Potassium bicarbonate was administrated to an already alkaline diet in seven male subjects during a 21-day bed rest study and was able to decrease bed rest induced increased calcium excretion but failed to prevent bed rest-induced bone resorption.

Introduction: Supplementation with alkali salts appears to positively influence calcium and bone metabolism and, thus, could be a countermeasure for population groups with an increased risk for bone loss. However, the extent to which alkalization counteracts acid-induced bone resorption or whether it merely has a calcium and bone maintenance effect is still not completely understood. In the present study, we hypothesized that additional alkalization to an already alkaline diet can further counteract bed rest-induced bone loss.

Methods: Seven healthy male subjects completed two parts of a crossover designed 21-day bed rest study: bed rest only (control) and bed rest supplemented with 90 mmol potassium bicarbonate (KHCO3) daily.

Results: KHCO3supplementation during bed rest resulted in a more alkaline status compared to the control intervention, demonstrated by the increase in pH and buffer capacity level (pH p = 0.023, HCO3p = 0.02, ABE p = 0.03). Urinary calcium excretion was decreased during KHCO3 supplementation (control 6.05 ± 2.74 mmol/24 h; KHCO3 4.87 ± 2.21 mmol/24 h, p = 0.03); whereas, bone formation was not affected by additional alkalization (bAP p = 0.58; PINP p = 0.60). Bone resorption marker UCTX tended to be lower during alkaline supplementation (UCTX p = 0.16).

Conclusions: The more alkaline acid-base status, achieved by KHCO3 supplementation, reduced renal calcium excretion during bed rest, but was not able to prevent immobilization-induced bone resorption. However, advantages of alkaline salts on bone metabolism may occur under acidic metabolic conditions or with respect to the positive effect of reduced calcium excretion within a longer time frame.

Trial registration: Trial number: NCT01509456.

Keywords: Bed rest; Bone metabolism; Calcium excretion; Potassium bicarbonate.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Bed Rest / adverse effects*
  • Bicarbonates / pharmacology
  • Bicarbonates / therapeutic use*
  • Biomarkers / metabolism
  • Bone Resorption / etiology
  • Bone Resorption / metabolism
  • Bone Resorption / prevention & control*
  • Calcium / urine
  • Cross-Over Studies
  • Dietary Supplements*
  • Humans
  • Hydrogen-Ion Concentration / drug effects
  • Immobilization / adverse effects
  • Immobilization / physiology
  • Male
  • Osteogenesis / drug effects
  • Potassium Compounds / pharmacology
  • Potassium Compounds / therapeutic use*
  • Weight-Bearing / physiology
  • Young Adult

Substances

  • Bicarbonates
  • Biomarkers
  • Potassium Compounds
  • potassium bicarbonate
  • Calcium

Associated data

  • ClinicalTrials.gov/NCT01509456